Ventyx Biosciences, Inc.
VTYX
$1.06
-$0.05-4.51%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 31.45M | 32.18M | 32.46M | 33.13M | 32.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 148.45M | 166.38M | 185.78M | 207.21M | 207.99M |
| Operating Income | -148.45M | -166.38M | -185.78M | -207.21M | -207.99M |
| Income Before Tax | -135.12M | -152.52M | -171.30M | -192.60M | -192.96M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -135.12 | -152.52 | -171.30 | -192.60 | -192.96 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -135.12M | -152.52M | -171.30M | -192.60M | -192.96M |
| EBIT | -148.45M | -166.38M | -185.78M | -207.21M | -207.99M |
| EBITDA | -148.18M | -166.12M | -185.55M | -207.01M | -207.84M |
| EPS Basic | -1.99 | -2.37 | -2.79 | -3.24 | -3.29 |
| Normalized Basic EPS | -1.24 | -1.48 | -1.74 | -2.03 | -2.06 |
| EPS Diluted | -1.99 | -2.37 | -2.79 | -3.24 | -3.29 |
| Normalized Diluted EPS | -1.24 | -1.48 | -1.74 | -2.03 | -2.06 |
| Average Basic Shares Outstanding | 273.86M | 262.13M | 250.34M | 238.34M | 234.15M |
| Average Diluted Shares Outstanding | 273.86M | 262.13M | 250.34M | 238.34M | 234.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |